chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Cough, SOB, Sore throat, fatigue, dry mouth, dizziness, GI  cramps, diarrhea, legs going to sleep.
Symptoms started on 7-26-2021 with muscle aches, runny nose, nausea/vomiting, headache, fatigue, diarrhea, loss of taste and smell, sinus pressure
Information has been received from a 47 year old female who was vaccinated with a dose of Zostavax. The patient reported that she "almost died from a medication given for shingles." Additional information has been requested.
Pt received 3 doses of IMOVAX as PEP after bat found in patients bedroom after 1st dose = fever & HA. 2nd dose = fever and HA. 3rd dose = fever, itch on back, stomach & hands. Sore throat, HA, progressing to weakness, tightened throat. ER diagnosed as type 2 anaphylactic reaction.
~5 minutes after administration, DD reported feeling chest tightness and radial pulse check showed rapid heart rate. No swelling, redness, or shortness of breath reported.    o         RN in monitoring area took vitals which showed BP 190/115 with HR 130 bpm. RN administered oral diphenhydramine 50mg x1 as thought was adverse/allergic reaction with no effect. Patient began feeling shaky and was transported to ED for further evaluation.   o         Patient was evaluated in the ED, where they reported sharp pain ~3 seconds in the left chest area. Chest CT and XRay and labs were drawn without any abnormality except hypomagnesaemia.    o         After monitoring and administration of 0.9% sodium chloride bolus and magnesium sulfate 1 gram x1 due to hypomagnesaemia, heart rate and hypertension resolved. Patient was educated and instructed to follow up outpatient and to return if symptoms worsened.
I had noticed a dot on my tongue and I didn't think anything of it. After about 2 months and post Dose 3 vaccine it started to grow. It expanded from the tongue to white spots on the inside of my cheeks. After a week or two I started to notice red dots on my arms that itched. By 01/2022 I noticed it was spreading to my legs. I did decide to see my doctor on 01/28/2022. He told me it was an allergic reaction nd gave a topical cream. He also said that I had thrush. They did a swab test to check if I had diabetes and it showed I did not. I had a follow up appointment 02/16/2022 and he advised it is not thrush and he is unsure what it was. he referred me to a dermatologist and an ENT. I had an appointment with the ENT on 03/10/2022. He said that it was an autoimmune disorder. They did a biopsy of my cheeks and he referred me to a rheumatologist. I did see the rheumatologist on 03/25/2022 and the diagnosis was lichen planus. 03/31/2022 I did see the dermatologist and she confirmed the diagnosis.
A lab technician reported that a 73 year old female received an injection of TD Toxoids Adsorbed, Purogenated on 8/30/00. The next day, the pt developed an injection site reaction characterized by hardness, warmth and swelling. She was treated with applications of ice to the affected area. The reporter indicated that 4 pts experienced an adverse event; however, only 1 is presently identifiable. Additional reports will be generated when identifying information is provided.
1st and 2nd dose given to a 14 year old; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st and 2nd dose given to a 14 year old) in a 14-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053C21A and 014C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-May-2021 at 9:48 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021 at 10:40 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st and 2nd dose given to a 14 year old). On 15-Jun-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st and 2nd dose given to a 14 year old) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant and treatment medications were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow up received indicated the patient did not experience any adverse reactions/ events after the administration of the vaccine. On 30-Aug-2021: The follow-up information received contain Non Significant Information.
called to see pt in vaccinator's room; pt sitting on exam table, increased RR, skin color white; pt diaphoretic, warm, responding to some questions; HOB placed flat and legs elevated; sweatshirt removed; mother at bedside telling pt that he is "all right"and states he has anxiety; VS at 1058:141/78; HR 64, regular; RR 22; SaO2 100%. At 1104 pt with slight tremors, continues to respond to questions; ice pak applied to neck; VS 133/84, HR 64, RR 20, SaO2 100%. 1115 pt without tremors, more awake, calm; HOB raised to 45 degrees; VS 122/72, HR 54, RR 18, SaO2 96%; Pt taking sips of Glucola and water, no c/o nausea; pt conversing appropriately. 1130 pt sitting at 90 degrees; states that he feels tired, no other c/o; VS 123/58, HR 55, RR 16, SaO2 97%. Pt ambulating in room, gait steady and strong; ambulated well in hallway. 1145-Pt left clinic stable, no c/o; mother accompanying pt and will drive pt home.
Pt was 26 weeks and 1 day pregnant when she got her 3rd Pfizer booster shot on Oct 2, 2021 at 2pm in the afternoon.  After the injection on the left arm, she felt it become sore after 3 hours, and it worsened after 6 hours.  On Oct 3rd, 2021 she had chills and a headache throughout the day and slept most of the day.  On Oct 4th, 2021 she realized that she had not felt the baby kick and contacted her doctor.  They told her to come into the hospital on Oct 4th 2021 and they determined that there was no long a heartbeat.  Ultrasound showed that the baby likely died a day ago. Pt vaginally delivered the stillborn baby boy on Oct 5th, 2021.  The baby was about 2 lbs.
Patient moved her arm and indicated where she wanted the injection given. Injection was given below the deltoid - question if it was given IM or SC. Flu injection re-given on 12/06/06.
Patient received her 4th oderna shot on 4/14/2022. Patient called the office on 4/25/22 stating she was having severe pain in her right arm where she was given the injection at and all the way down to her fingers and Tylenol Arthritis was not touching the pain. Patuent was told to ice it and given Rx for Tramadol to try. Patient then came for an appointment on 5/5/22 presenting with a rash that is bullous and also appears to be vasculitis on the right arm meially that started ~3 days prior from the armpit to the palm of hand with some lesions on the chest and shoulder blade area. Patient has tried ice, heat, pain relief gel, Tylenol Arthritis, Ibuprofen, Tramadol, Prednisone burst, Iodoform Guaze, mupirocin ointment Vaseline, Calamine lotion, hydrocortisone cream, Gabapentin, and Silvadene ointment. Patient has a follow up on 5/26/22.
@ 5AM on 9MAY97 pt woke up @ home, mom heard high pitched squeaking cry, one episode only lasting 15" no fever, no other noted sx;
I was preparing a Boostrix and  a Shingrix each for a married couple. On the second Shingrix I recapped the needle after drawing up the adjuvant to stop and put a phone call on hold. I then forgot to mix the adjuvant in the antigen and administered the shot. Because I took all shots out at the same time and I can not see the shot booth from the cameras I am not sure which patient got the shot that did not have the adjuvant. I noticed the mistake when I was about to throw the vials in the sharps after administration and noticed one of the vials was white. Patient is well and had no adverse reaction.
abdominal cramping; diarrhea; nausea; hot and cold sweats; hot and cold sweats; 99.1F temperature; fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 08Apr2021 at 11:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included family history of Irritable Bowel Syndrome (IBS), heart disease and cancer and the patient was diagnosed with depression and anxiety and was allergic to red onions. Concomitant medications included propranolol (MANUFACTURER UNKNOWN), venlafaxine (MANUFACTURER UNKNOWN), drospirenone, ethinylestradiol betadex clathrate (YAZ) and bupropion (MANUFACTURER UNKNOWN), all taken from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 23:45, 12 hours after the vaccination, the patient experienced 40 minutes of extreme abdominal cramping, diarrhea, nausea, hot and cold sweats and 99.1 Fahrenheit temperature followed by fatigue. Therapeutic measures were not taken as a result of the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event abdominal cramps was resolved on 09Apr2021, while the outcome of the events diarrhea, nausea, hot and cold sweats and 99.1 Fahrenheit temperature followed by fatigue were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Pt reports post vaccine red area deltoid, warm to touch, erythema a area 3" diameter to Rt deltoid. Treated with steroids.
Patients father said his son began throwing up 2 days after injection. They  took him to the ER and patient was given some medication to stop emesis. Two days later patient was still throwing up and the ER told him to give the medication a couple more days to work. The father said the throwing up was not constant and patient was able to eat and keep it down. The emesis was reported as dark brown mucous   with no food particles in it. Patient was reported to throw up everyday until his death on day 9.
HIGH BP AND PULSE BETWEEN 9:30 PM AND MIDNIGHT THE EVENING AFTER THE VACCINE:  175/99 PULSE 149,   151/79 PULSE 115, 154/73 PULSE 139, 163/77 PULSE 137.
pt recv vax; 10sep94 devel a 104 fever, nasal, congestion & joint pain;
a lot of side effects/felt like covid; feeling dreadful for a weekend; arm tenderness; horrible headache; exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (a lot of side effects/felt like covid), FEELING ABNORMAL (feeling dreadful for a weekend), TENDERNESS (arm tenderness), HEADACHE (horrible headache) and FATIGUE (exhaustion) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A, 005C21A and 939903) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in March 2021.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (a lot of side effects/felt like covid), FEELING ABNORMAL (feeling dreadful for a weekend), TENDERNESS (arm tenderness), HEADACHE (horrible headache) and FATIGUE (exhaustion). At the time of the report, VACCINATION COMPLICATION (a lot of side effects/felt like covid), FEELING ABNORMAL (feeling dreadful for a weekend), TENDERNESS (arm tenderness), HEADACHE (horrible headache) and FATIGUE (exhaustion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient stated that she experienced the longest and worst side effects with the first dose. Concomitant medications include Birth control. Treatment medications include Aleve.   This case was linked to MOD-2021-426881, MOD-2021-426691, MOD-2021-426900 (Patient Link).
A powder vial left in the box and not sure which patient didn't receive / they believe that a 16 year old patient; A powder vial left in the box and not sure which patient didn't receive / they believe that a 16 year old patient; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMXA437A, expiry date unknown) for prophylaxis.   On 21st June 2021, the patient received the 2nd dose of Menveo. On 21st June 2021, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The reporter stated that, they believe that a 16-year-old patient received a single dose but only received the diluent portion of the vaccine for the booster dose, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter asked that would it be harmful if a patient received an extra Menveo vaccination, as they were not sure if she received the 2nd dose. The reporter stated that, there were 3 patients that day that it was ordered but not sure which patient did not receive, there was a powder vial left in the box, but the reporter was going to offer them to come in and get another dose but not sure if it would be a 3rd dose. The reporter inquired about a 3rd dose. The reporter consented to follow up via email.
1st reported on 9-7-2016- phone call to pharmacy. Diarrhea for 3 days with some shaking in the hands (EPR) slowly recovered by weeks end 9-11-16. Still has some shakiness as of 9/16/16.
2 days after MMR vaccine was given patient lost consciousness and, possibly had a mild seizure.
received the vaccine around 0930.  Shortly after i started feeling very dizzy, nauseated, and stomach was cramping.  By 1130 I had to leave work.  I barely could drive home.  Went home and tried to lay down to rest.  The nausea was overwhelming.  I began to throw up and was not able to hold anything down all weekend.  I had zofran at home and tried to take that only to throw it up as well.  The nausea was severe.  My mouth would fill with water and then I would puke.  I noticed fatigue, stomach cramping, nausea, pain at the site of the injection, headache, and became dehydrated.  i had to go to the ER by Tuesday.  My primary care told me to go.  They gave me fenergen and an IV.  Finally  I got pedialyte and light food to stay down.  As of today I am feeling better but my stomach is swollen and very gassy.  Like its upset.  I barely have an appetite.
Pt recvd 2 doses of Engerix-B 3OCT91 & 4DEC91 dose 1 was uneventful; 5DEC91 vax exp h/a, malaise;
Red itchy patch noted on her right arm (injection site); This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Red itchy patch noted on her right arm (injection site)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PRURITUS (Red itchy patch noted on her right arm (injection site)). At the time of the report, PRURITUS (Red itchy patch noted on her right arm (injection site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No relevant concomitant medications were reported.   No treatment information was provided.
Expired vaccine stored in refrigerator (Refrigeration date was 22-Sep-2021, expiration Date was 03-Oct-2021 and administration date was 29-Nov-2021); dose was given after expiration date; First dose was given on 19-Oct-2021 and second dose was given on 29-Nov-2021 (more than 35 days after first dose); This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose was given on 19-Oct-2021 and second dose was given on 29-Nov-2021 (more than 35 days after first dose)) and PRODUCT STORAGE ERROR (Expired vaccine stored in refrigerator (Refrigeration date was 22-Sep-2021, expiration Date was 03-Oct-2021 and administration date was 29-Nov-2021)) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 047B21A) for COVID-19 vaccination.  No Medical History information was reported.  On 19-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose was given on 19-Oct-2021 and second dose was given on 29-Nov-2021 (more than 35 days after first dose)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vaccine stored in refrigerator (Refrigeration date was 22-Sep-2021, expiration Date was 03-Oct-2021 and administration date was 29-Nov-2021)). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose was given on 19-Oct-2021 and second dose was given on 29-Nov-2021 (more than 35 days after first dose)) and PRODUCT STORAGE ERROR (Expired vaccine stored in refrigerator (Refrigeration date was 22-Sep-2021, expiration Date was 03-Oct-2021 and administration date was 29-Nov-2021)) outcome was unknown.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  The reporter was infection control manager.  Concomitant medication of the patient was not reported.  There was no temperature excursion. The reporter reported that there was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned.  The patient did not experience any adverse event.  No treatment information was provided by the reporter.   This case was linked to MOD-2022-504729 (Patient Link).
Vet states he is having right-sided chest pain under his right breast.  It stared about 2 weeks ago which was two weeks after getting the Janssen vaccine.  he heard the vaccine was causing lung clots and he wanted to notify us.
Tingling of tongue and roof of mouth.  The back of throat felt swollen.  Did not have difficulty breathing but felt a couple of wheezing breaths.  Lasted about 30 minutes.  No symptoms after 30 minutes except for the sore site of injection.
tested for Covid Wednesday 10Mar2021, first dose 27dec2020, 2nd dose 14jan2021,Severe headache, fatigue, cough and congestion  on 09mar2021; tested for Covid Wednesday 10Mar2021, first dose 27dec2020, 2nd dose 14jan2021,Severe headache, fatigue, cough and congestion  on 09mar2021; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age (unknown if pregnant) received first dose (lot number: EK9231) on 27Dec2020, second dose (lot number: EL1283) of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), both via an unspecified route of administration, single dose for covid-19 immunisation. The patient's medical history was not reported. There were no concomitant medications. The patient experienced Severe headache, fatigue, cough and congestion began on Tuesday 09Mar2021, tested for Covid Wednesday 10Mar2021, positive results received Thursday 11Mar2021 and reporter notified Friday 12Mar2021. The outcome of the events was unknown. Unknown if treatment were given for the adverse events.
A spontaneous, serious report of allergic reaction has been received from a physician concerning a four-year-old male subsequent to receiving FLUMIST. This case is submitted in accordance with MedImmune's post-marketing commitment on accelerated reporting for the newly indicated population of 2 years to 59 months of age for FLUMIST. Medical history included previous flu vaccinations and concomitant medications were not reported. On an unknown date in Nov-2009, the patient received FLUMIST for the first time. Shortly after the patient received FLUMIST (date unknown), the patient presented to the emergency department with hives and angioedema. The patient was treated with steroids and H2 blockers. He was sent home and was to take diphenhydramine and oral prelone 1mg/kg divided twice a day for 3 days then 3 days at 1/2 dose at home. On 16-Nov-2009, the patient returned to the ED for persistent hives without respiratory compromise. No further information was available. The outcome of the event, allergic reaction, was unknown. The physician assessed the event of allergic reaction as related to FLUMIST. Required follow up attempts have been performed, requested information unable to be obtained.  23-Feb-2010.
1st Shot: slight temperature 100.3 and sight of injection was sore to press on. 2nd Shot: 103.6 Temp most of first night, arm sore to move, not painful to press on. Slight balance problem, not hungry, stomach a bit queasy.
Moderna COVID?19 Vaccine EUA  Lymphadenitis over left clavicle, evaluated with ultrasound.  No treatment needed, will follow clinically, with PCP follow up if it persists.
Arm was tender; Pain in the injection site; Swelling in the injection site; A spontaneous report, was received from a consumer (patient), a 35 years-old female patient, unknown race and ethnicity, who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced arm was tender (tenderness), pain in the injection site (injection site pain), and swelling in the injection site (injection site swelling).  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 24 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot# 037K20A), intramuscularly in the arm for prophylaxis of COVID-19 infection.   On 24 Dec 2020, after administration of the vaccine, the patient experienced pain and swelling on the injection site and arm was tender. No treatment information was provided.   Action taken with second dose of mRNA-1273 in response to the events was not reported.   The outcome of the events, arm was tender, pain in the injection site, and swelling in the injection site, were considered as not recovered.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Extreme muscle pain, chills, slight fever, dizziness. Passed out in the morning after getting up.